Global Kidney Cancer Therapeutics & Diagnostics Market

The occurrence of kidney cancer has increased in the recent years. Excessive smoking, rise in obesity because of sedentary life routines and increased consumption of alcohol are some of the causes of kidney cancer. The most common type of cancer is Renal Cell Carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma. Almost 9 out of 10 kidney cancers are renal cell carcinomas. Another type of kidney cancer present among a few individuals is transitional cell carcinoma (TCC). 5% to 10% of the kidney cancer patients in the U.S. suffer from this type of cancer.

Immunotherapies or targeted therapies are the most common prescribed treatments for kidney cancer. Sometimes RCC cannot be treated by surgeries alone. Especially if a person has developed metastatic cancer, additional treatment regimens could be recommended. Since the targeted therapies are known to act at the cellular level, their effectiveness and accuracy increases with reduced toxicity. The only life-prolonging treatment regimens that are available to patients with advanced stage metastatic tumor are the kidney cancer drugs.

Market Dynamics

Due to the various factors such as increasing geriatric population, rising occurrences of kidney cancer and approval of novel drugs, the global kidney cancer therapeutics and diagnostics market is expected to grow at a stable rate during the forecast period. However, there are also some limiting factors that may negatively impact the growth of the market, such as increasing preference for generic drugs variants and high prices of branded cancer drugs.

Drivers:

--> Increasing kidney cancer cases

--> Technological developments

--> Drug innovations with regard to the kidney cancer

--> Government initiatives

--> Rise in aging populace

--> Advanced health care

--> Upsurge in awareness about kidney diseases and their existing therapies in the market

--> Increasing health care expenditure

Restraints:

--> Rise in number of patent expirations

--> Rise in use of generic drugs

--> Low success rate in clinical trials

--> Regulatory affairs

Market Segmentation

Segmentation of global kidney cancer therapeutics & diagnostic market based on:

--> Type

o Renal cell carcinoma

o Transitional Cell Cancer

o Renal sarcoma

o Other rare types

--> Major tests

o Cystoscopy

o Biopsy

o Intravenous pyelogram

o CT Scan an

o Kidney Ultrasound.

--> Geography

o Asia-Pacific

o North America

o Europe

o Latin America

Opportunities

North America dominates the global kidney cancer therapeutics and diagnostics market. The major factor driving the growth in this region is the increasing number of kidney cancer cases. However, the region of Asia-Pacific is expected to be the fastest growing market during the forecast period. Rising patient base suffering from RCC, growing patient awareness and lower costs of drug production are expected to drive the growth of this market.

Key Players

--> Bayer

--> Hoffmann La Roche

--> GlaxoSmithKline

--> Novartis

--> Pfizer

--> Abbott Laboratories

--> Amgen

--> Genentech

--> Cerulean Pharma

--> Seattle Genetics

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage